Literature DB >> 21445701

[Cutaneous cytotoxic T-cell lymphoma].

A Weinstabl1, M Megahed, A Rütten, A Rübben.   

Abstract

Cutaneous cytotoxic T-cell lymphoma is a rare variant of cutaneous T-cell lymphoma, which shows immunoreactivity for CD56+. We report on an 83-year old woman with numerous skin infiltrates and nodules mainly on her face and trunk. Histopathologic criteria lead to the diagnosis of cutaneous cytotoxic T-cell lymphoma. Bexarotene was not tolerated because of cardiac insufficiency, but treatment with methotrexate (7.5 mg once weekly) led to prompt regression of all lesions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21445701     DOI: 10.1007/s00105-011-2165-2

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  8 in total

Review 1.  Classification of cutaneous T-cell lymphoma: from Alibert to WHO-EORTC.

Authors:  Rein Willemze; Chris J L M Meijer
Journal:  J Cutan Pathol       Date:  2006-02       Impact factor: 1.587

Review 2.  Management of refractory early-stage cutaneous T-cell lymphoma.

Authors:  Margit A Huber; Gyde Staib; Hubert Pehamberger; Karin Scharffetter-Kochanek
Journal:  Am J Clin Dermatol       Date:  2006       Impact factor: 7.403

Review 3.  Novel therapies for cutaneous T-cell lymphomas.

Authors:  Steven M Horwitz
Journal:  Clin Lymphoma Myeloma       Date:  2008-12

Review 4.  Therapy of cutaneous lymphoma--current practice and future developments.

Authors:  R Dummer; W Kempf; M Hess Schmid; A Häffner; G Burg
Journal:  Onkologie       Date:  2003-08

Review 5.  Choices in the treatment of cutaneous T-cell lymphoma.

Authors:  Kenneth B Hymes
Journal:  Oncology (Williston Park)       Date:  2007-02       Impact factor: 2.990

6.  Treatment of cutaneous lymphomas: today and tomorrow.

Authors:  D S Mestel; M Beyer; M Steinhoff; W Sterry
Journal:  Actas Dermosifiliogr       Date:  2009-11

7.  Cutaneous lymphomas: from morphology to chip technology.

Authors:  L Cerroni; T Wiesner
Journal:  Actas Dermosifiliogr       Date:  2009-11

Review 8.  Current and emerging treatment strategies for cutaneous T-cell lymphoma.

Authors:  Frederick Lansigan; Francine M Foss
Journal:  Drugs       Date:  2010-02-12       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.